tm logo
DUAVEE
Live/Registered
REGISTERED AND RENEWED

on 11 Apr 2024

Last Applicant/ Owned by

66 Hudson Boulevard East

New York

NY

10001-219

Serial Number

85840812 filed on 05th Feb 2013

Registration Number

4544493 registered on 03rd Jun 2014

in the Principal Register

Correspondent Address

Andrea Christensen

Andrea Christensen Pfizer Inc.

New York, NY 10001-2192

UNITED STATES

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

DUAVEE

Pharmaceutical preparations for treating symptoms associated with menopause; pharmaceutical preparations for the prevention of postmenopausal bone loss; pharmaceutical preparations for the treatment of vasomotor symptoms, namely, hot flashes, due to menopause

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical preparations for treating symptoms associated with menopause; pharmaceutical preparations for the prevention of postmenopausal bone loss; pharmaceutical preparations for the treatment of vasomotor symptoms, namely, hot flashes, due to menopause


First Use Date in General

03rd Feb 2014

First Use Date in Commerce

03rd Feb 2014

Mark Details


Serial Number

No 85840812

Mark Type

No Service/Collective Mark

Attorney Docket Number

No T401968

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
11th Apr 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
11th Apr 2024REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
11th Apr 2024REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
11th Apr 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
30th Nov 2023TEAS SECTION 8 & 9 RECEIVED
03rd Jun 2023COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
06th Apr 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
06th Apr 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
06th Apr 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06th Apr 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED